Methylprednisolone → 6alpha-Methylhydrocortisone

HRID 1695550노트

반응식

HRID 1695550 반응식
[OH:1][C@@H:2]1[C@H:18]2[C@@H:9]([CH2:10][C@H:11]([CH3:21])[C:12]3[C@:17]2([CH3:19])[CH:16]=[CH:15][C:14](=[O:20])[CH:13]=3)[C@H:8]2[C@@:4]([CH3:27])([C@@:5]([OH:26])([C:22](=[O:25])[CH2:23][OH:24])[CH2:6][CH2:7]2)[CH2:3]1.[H][H]>CCOC(C)=O.C(O)C>[OH:1][C@@H:2]1[C@H:18]2[C@@H:9]([CH2:10][C@H:11]([CH3:21])[C:12]3[C@:17]2([CH3:19])[CH2:16][CH2:15][C:14](=[O:20])[CH:13]=3)[C@H:8]2[C@@:4]([CH3:27])([C@@:5]([OH:26])([C:22](=[O:25])[CH2:23][OH:24])[CH2:6][CH2:7]2)[CH2:3]1

참가 물질

5

반응물 2

HCID 6741MethylprednisoloneHCID 178418361HCID 178418361, 화합물

생성물 1

HCID 1021476alpha-Methylhydrocortisone수율 94.2%

시약·촉매·용매 2

HCID 702Ethanol용매HCID 8857Ethyl Acetate용매

실험 절차

In a 250 mL round-bottomed flask was suspended (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (6α-Methyl-Prednisolone, 4.3 g, 11.48 mmol) in EtOAc (80 mL) and the reaction mixture was diluted with ethanol (20.0 mL). Wilkinsons catalyst (1 g, 1.08 mmol) was added and the mixture was hydrogenated for 1 week whilst stirring at room temperature in a hydrogen atmosphere (1 atm). The mixture was filtered and the filtrate was concentrated in vacuo, giving 4.07 g of a light brown solid. The material was used as such without any further purification. APCI-MS m/z: 377 [MH+].

후처리

  1. customIn a 250 mL round-bottomed flask was suspended
  2. additionwas added
  3. waitthe mixture was hydrogenated for 1 week
  4. filtrationThe mixture was filtered
  5. concentrationthe filtrate was concentrated in vacuo

출처 및 근거

ORD 기록
ord-2db88380a7dc447793156a1795bdc966
출처 데이터셋
uspto-grants-2012_04
특허 번호
US08163724B2

반응 노트

불러오는 중…